News | June 16, 2026
New offering bridges the gap between technology expectations and real-world performance, helping clients manage disputes, remediation efforts, and emerging technologies.
May 29, 2024
Pablo Varas authored an article summarizing the 2024 ABA Antitrust Spring Meeting session on healthcare mergers. The panelists discussed recent healthcare merger enforcement actions and how companies are seeking to overcome those challenges. The article highlights key lessons from recent healthcare mergers, in particular the IQVIA-Propel, Amgen-Horizon, and Illumina-Grail mergers. It also gives an outline of recent enforcement actions in hospital mergers and some key topics that appear to interest enforcers when reviewing proposed mergers.
Read the article (membership may be required) here.
New offering bridges the gap between technology expectations and real-world performance, helping clients manage disputes, remediation efforts, and emerging technologies.
What Companies Should Be Watching in Securities Enforcement for the Remainder of 2026
Companies face a shifting securities enforcement landscape in H2 2026, where AI, digital assets, prediction markets, and parallel investigations create new risks even as financial reporting and controls remain core priorities driving more targeted, tech-focused, and multi-agency scrutiny.
Algorithmic Pricing, Antitrust Risk, and the Role of Economic Analysis
Recent DOJ settlements and new California and New York legislation are clarifying antitrust risks around algorithmic pricing. This article examines key enforcement themes, high-risk forms of data sharing and information exchange, and the role of economic analysis in assessing algorithm design, adoption, competitive effects, and compliance risk.